Healthcare leaders gathered in San Francisco for a major industry event. This conference, known for its massive turnout and high-energy atmosphere, brought together CEOs from big and small drug companies. The buzz was around GLP-1 drugs, which have transformed diabetes and obesity treatment and are
The internet is full of fake weight-loss drugs. Scammers are taking advantage of the growing interest in GLP-1 medications like Ozempic and Mounjaro. These drugs are expensive, so people are looking for cheaper options. But be careful! Many fake versions are out there, and they might not work or eve
Ever wonder why people use the terms "left" and "right" to describe political views? These labels are often used to categorize people, but the reality is much more complex. The truth is, these labels don't always fit neatly. They can be misleading, oversimplifying the diverse range of opinions and b
People are talking about how weight-loss drugs like Ozempic and Zepbound are changing lives. These drugs do more than just help with weight. They can also shake up relationships. One couple's story shows how these drugs can cause big changes. The wife started taking Ozempic. She lost weight and fel
Novo Nordisk has introduced a new pricing strategy for its weight-loss drugs, Ozempic and Wegovy. Starting now, people without insurance can buy the lowest doses for $199 a month for two months. After that, the price jumps to $349. This deal is available through the drugs' websites and select pharma
Employers are bracing for a significant hike in health care costs next year, with a median increase of 9 percent expected. This trend is largely driven by the rising use of GLP-1 drugs for obesity and diabetes, as well as the increasing prevalence and cost of cancer treatments. The survey, which inc
Polycystic ovary syndrome (PCOS) is a common but often misunderstood condition affecting millions of women. It can cause a range of symptoms, from irregular periods and weight gain to infertility and mental health struggles. For years, treatments have been limited, but a new class of drugs originall
Semaglutide, the key component in Ozempic and Wegovy, might offer more than just weight loss and diabetes management. Recent research suggests it could also lower dementia risk in type 2 diabetes patients. Scientists from Case Western Reserve University discovered this link, publishing their finding
Alcohol use disorder remains a major public health challenge in the United States. There are a number of new medications undergoing clinical trials. One promising example is semaglutide, the main ingredient in Ozempic. The drug's success in treating type 2 diabetes has paved the way for its explo
NYC's health plan for city employees recently scrapped coverage for weight loss drugs called GLP-1s. Almost 400, 000 employees are affected, many of whom find these drugs quite effective. But the city says it'll save money by doing this. Interestingly, other chronic diseases like diabetes usually ge
